Sepsis and organ failure are the major risks for allogeneic transplant patients in the post- or late- engraftment phase admitted to the ICU.
Hematology (Amsterdam, Netherlands)
View this publicationHematology (Amsterdam, Netherlands)
View this publicationFrontiers in immunology
View this publicationFrontiers in immunology
View this publicationFrontiers in oncology
View this publicationNature medicine
View this publicationJournal for immunotherapy of cancer
View this publicationJournal of cancer research and clinical oncology
View this publicationBlood
View this publicationNeuro-oncology advances
View this publicationJAMA oncology
View this publication